Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations

M. Fanin, D. J. Duggan, M. L. Mostacciuolo, F. Martinello, M. P. Freda, G. Sorarù, C. P. Trevisan, E. P. Hoffman, C. Angelini

Research output: Contribution to journalArticlepeer-review


Background - The autosomal recessive limb-girdle muscular dystrophies (LGMDs) are a group of genetically heterogeneous muscle diseases characterised by progressive proximal limb muscle weakness. Six different loci have been mapped and pathogenetic mutations in the genes encoding the sarcoglycan complex components (α-, β-, γ-, and δ-sarcoglycan) have been documented. LGMD patients affected with primary 'sarcoglycanopathies' are classified as LGMD2D, 2E, 2C, and 2F, respectively. Methods - A geographical area in north east Italy (2,319,147 inhabitants) was selected for a genetic epidemiological study on primary sarcoglycanopathies. Within the period 1982 to 1996, all patients living in this region and diagnosed with muscular dystrophy were seen at our centre. Immunohistochemical and immunoblot screening for α-sarcoglycan protein deficiency was performed on all muscle biopsies from patients with a progressive muscular dystrophy of unknown aetiology and normal dystrophin. Sarcoglycan mutation analyses were conducted on all patient muscle biopsies shown to have complete or partial absence of α-sarcoglycan immunostaining or a decreased quantity of α-sarcoglycan protein on immunoblotting. Results - Two hundred and four patient muscle biopsies were screened for α-sarcoglycan protein deficiency and 18 biopsies showed a deficiency. Pathogenetic mutations involving one gene for sarcoglycan complex components were identified in 13 patients: α-sarcoglycan in seven, β-sarcoglycan in two, γ-sarcoglycan in four, and none in the δ-sarcoglycan gene. The overall prevalence of primary sarcoglycanopathies, as of 31 December 1996, was estimated to be 5.6 x 10-6 inhabitants. Conclusion - The prevalence rate estimated in this study is the first to be obtained after biochemical and molecular genetic screening for sarcoglycan defects.

Original languageEnglish
Pages (from-to)973-977
Number of pages5
JournalJournal of Medical Genetics
Issue number12
Publication statusPublished - 1997


  • Autosomal recessive limb-girdle muscular dystrophy
  • Duchenne-like muscular dystrophy
  • Sarcoglycan complex

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations'. Together they form a unique fingerprint.

Cite this